Patents for C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535)
06/2005
06/29/2005CN1633237A Novel SPINOSYN-producing polyketide synthases
06/29/2005CN1632116A Enhancement of virus-mediated DNA transfer
06/29/2005CN1632114A Process for producing high active pancreatin
06/29/2005CN1632113A Process for extracting natural plant enzyme by extraction of pawpaw latex
06/29/2005CN1632112A Process for electric field enhanced solid fermentation preparation of cellulase
06/29/2005CN1632111A Process for producing cellulase by semicontinuous solid fermentation-extraction coupling
06/29/2005CN1632110A Modified high specific activity phytase, gene encoding same and high expression thereof
06/29/2005CN1632106A Hypothermal alkaline metal protease of marine microorganism and its enzyme producing strain
06/29/2005CN1632102A Yeast engineering bacterium of high productive glycerin
06/29/2005CN1208456C Recombination in vivo
06/29/2005CN1208455C Method of preparing catalase using extraction method
06/29/2005CN1208454C Process for biologically synthesizing extracellular cholesterol oxidase from Brevibacterium and its transferred product cholest-4-ene-3-one
06/29/2005CN1208452C Glutamine transaminase high productive bacteria and its screening method and fermentation method producing glutamine transaminase using said bacterial strain
06/29/2005CN1207980C Feed complex enzyme preparation and preparing process thereof
06/28/2005US6912470 Nucleotide sequences coding enzymatic polypeptide for use in the production of anticarcinogenic and infection agents
06/28/2005US6911576 Transgenic poplar trees comprising glutamine synthetase from pine having improved nitrogen metabolism and methods of making and using the same
06/28/2005US6911545 Crystals of glucokinase and methods of growing them
06/28/2005US6911541 Nucleotide sequences for use in reducing nicotine concentration in tobacco
06/28/2005US6911535 Biomolecule/polymer conjugates
06/28/2005US6911467 Useful for the treatment of type 2 diabetes, impaired glucose tolerance and certain other conditions
06/28/2005US6911428 Diaryl peptides as NS3-serine protease inhibitors of hepatitis C virus
06/28/2005US6911341 Vectors, host cells, and methods for production of uridine phosphorylase and purine nucleoside phosphorylase
06/28/2005US6911337 Nucleic acids encoding β-1,4-GalNAc transferase
06/28/2005US6911336 GNK interacting amino acid decarboxylase and methods of use thereof
06/28/2005US6911335 57316 and 33338, human ubiquitin carboxyl terminal hydrolases and uses therefor
06/28/2005US6911334 Protease for activating clotting factor VII
06/28/2005US6911333 Gene has a mutation or deletion of part of the genes, encoding a serine protease cleaning composition; biosynthesis
06/28/2005US6911331 Nucleotide sequences coding polypeptide for use in the generation of disease and herbicide resistant plants
06/28/2005US6911330 Recombinant secoisolariciciresinol dehydrogensase, and methods of use
06/28/2005US6911329 Process for the fermentative preparation of D-pantothenic acid using coryneform bacteria
06/28/2005US6911327 Determining starting amount of target nucleotide sequences; amplify nucleotide sequences, amplify control, determine threshold points, calculate propagation curve, determine starting amount of nucleotide sequences
06/28/2005US6911326 N-acetylglucosamine-1-phosphate uridyltransferase (GlmU) for producing uridine 5'-diphosphate-N-acetylglucosamine using Corynebacterium glutamicum; genetic engineering
06/28/2005US6911322 Comprises genetically engineered subtilisin regulatory sequence for increasing expression of heterologous proteins such as proteases, lipases and amylases in bioreactors/trangenic cells
06/28/2005US6911317 2150, human protein kinase family member and uses therefor
06/28/2005US6911316 Single chain urokinase type plasminogen activator (scuPA)/ soluble urokinase plasminogen activator receptor (suPAR); for the treatment/prevention of thromboembolic disorders associated with the formation of fibrin clots
06/28/2005US6911314 Screening for drugs that affect TNF receptor releasing enzyme
06/28/2005US6911309 Nucleic acids encoding MTAse
06/28/2005US6911199 Targeted adenovirus vectors for delivery of heterologous genes
06/28/2005CA2261094C Chimera gene with several herbicide resistant genes, plant cell and plant resistant to several herbicides
06/28/2005CA2232230C Phosphopantetheinyl transferases and uses thereof
06/28/2005CA2151146C Use of a dna sequence coding for an oxalic acid degrading protein as a selection gene
06/28/2005CA2129660C Tissue plasminogen activator glycosylation variants with improved therapeutic properties
06/23/2005WO2005056835A1 A novel phytase gene derived from penicillium oxalicum and a pichia pastoris transformant producing the phytase
06/23/2005WO2005056825A1 Screening for modulators of mekk2 and mekk3
06/23/2005WO2005056822A1 Method of judging clinical malignancy of fals
06/23/2005WO2005056816A1 Charcoal stabilization of phenyl phosphates
06/23/2005WO2005056815A1 Nitroreductase biosensors for detecting nitro-compounds
06/23/2005WO2005056808A2 Immobilization of biocatalysts by template-directed silicate precipitation
06/23/2005WO2005056803A1 Sesquiterpene synthases from patchouli
06/23/2005WO2005056802A2 Materials and methods relating to cell cycle control
06/23/2005WO2005056801A1 Polynucleotides and polypeptides isolated from lactobacillus rhamnosus hn001 materials incorporating them and methods for using them
06/23/2005WO2005056787A1 Surfactant-tolerant cellulase and method of converting the same
06/23/2005WO2005056786A2 Sugar kinases with expanded substrate specificity and their use
06/23/2005WO2005056785A2 Crystal structure of interleukin-2 tyrosine kinase (itk) and binding pockets thereof
06/23/2005WO2005056784A1 Insulin-inducible polypeptide
06/23/2005WO2005056783A1 Catalytic domains of beta(1,4)-galactosyltransferase i having altered metal ion specificity
06/23/2005WO2005056782A2 Perhydrolase
06/23/2005WO2005056776A1 E.coli mutant containing mutant genes related with tryptophan biosynthesis and production method of tryptophan by using the same
06/23/2005WO2005056772A1 Methods for eliminating or reducing the expression of genes in filamentous fungal strains
06/23/2005WO2005056771A2 In vitro uptake of spam 1 (ph-20) by mammalian sperm
06/23/2005WO2005056757A2 A method for the positive selection of chromosomal mutations in c1 metabolizing bacteria via homologous recombination
06/23/2005WO2005056752A2 Methods and compositions for delivering polynucleotides
06/23/2005WO2005056594A1 Akt ACTIVITY SPECIFICALLY INHIBITING POLYPEPTIDE
06/23/2005WO2005056043A2 Use of enzymatic inhibitors of h-prune for the prevention and treatment of the metastases of tumours overexpressing h-prune
06/23/2005WO2005056039A1 Self-assembling peptide amphiphiles and related methods for growth factor delivery
06/23/2005WO2005056035A1 Alga extract and sugar hydrolase inhibitor containing the same
06/23/2005WO2005056034A1 Alga extract and lipase inhibitor containing the same
06/23/2005WO2005055706A1 DISEASE MODEL ANIMAL EXPRESSING MEGSIN/RAGE/iNOS AND METHOD OF EVALUATING COMPOUND WITH THE USE OF THE ANIMAL
06/23/2005WO2005055704A2 Wheat having reduced waxy protein due to non-transgenic alterations of a waxy gene
06/23/2005WO2005049787A9 Compositions and methods for in vitro sorting of molecular and cellular libraries
06/23/2005WO2005035746A3 Medical use of tbk-1 or of inhibitors thereof
06/23/2005WO2005034978A3 MEDICAL USE OF IKKϵ OR OF INHIBITORS THEREOF
06/23/2005WO2005031359A3 Diagnostics and therapeutics for diseases associated with arginyl aminopeptidase rnpep (rnpep)
06/23/2005WO2005030947A3 Diagnostic and therapeutic use of a sulfotransferase for neurodegenerative diseases
06/23/2005WO2005030798A3 TNFαCONVERTING ENZYME INHIBITORY AGENTS AND STIMULATORY AGENTS-
06/23/2005WO2005030032A3 Use of islet glucose-6-phosphatase related protein as a diagnostic tool and therapeutic target for autoimmune diabetes
06/23/2005WO2005023833A3 Treatment of neurodegenerative diseases
06/23/2005WO2005015205A3 Use of sap
06/23/2005WO2005007814A3 Genome mapping of functional dna elements and cellular proteins
06/23/2005WO2004106365A3 Modulatory peptide motifs for inducing th1 or th2 immune response
06/23/2005WO2004096142A3 Alk protein tyrosine kinase, cells and methods embodying and using same
06/23/2005WO2004074498A3 Expression of class 2 mannosidase and class iii mannosidase in lower eukaryotic cells
06/23/2005WO2004069190A3 Combination therapy for treating protein deficiency disorders
06/23/2005WO2003102163A8 Methods of diagnosing and treating diabetes and insulin resistance
06/23/2005US20050138688 Starch Hydrolytic Enzyme; similar, in general terms, to previously known alpha-amylases since both activities are able to hydrolyze starch, amylopectin, amylose, and beta-limit dextrin but are not able to hydrolyze the branched polymer pullulan
06/23/2005US20050137386 Expression vector comprising nucleotide sequences coding citrate synthase and malate dehydrogenase for use in generating plants resistant presence aluminum in soils; pollution control
06/23/2005US20050137157 administering polynucleotides coupled to thymidine kinase genes, that convert prodrugs such as acyclovir, ganciclovir, fialuridine or 6-methoxypurine arabinoside, to cytotoxic compounds, used for tissue targeted therapy in the treatment of pancreatic cancers
06/23/2005US20050137112 determining lymphocyte epitopes in proteins comprising obtaining from blood, a solution of dendritic cells and CD4 antigens, then promoting cell differentiation, by exposing to cytokines, then mixing with peptides of interest and measuring the proliferation of lymphocytes
06/23/2005US20050137111 Thermostable amylase polypeptides, nucleic acids encoding those polypeptides and uses thereof
06/23/2005US20050136539 Generating immortalized human renal proximal tubule epithelial cell (RPTEC) for use as model for identifying modulators of renal toxicity
06/23/2005US20050136537 Modulating sirtuin deacetylase protein; apoptosis; using flavone, stilbene, isoflavone, sphingosine; stroke; cardiovascular disorders; antiarthritic agents; Alzheimer's disease
06/23/2005US20050136525 Expression of granular starch hydrolyzing enzymes in Trichoderma and process for producing glucose from granular starch substrates
06/23/2005US20050136524 Non-maltogenic exoamylase for use in improving quality of dough and baked goods
06/23/2005US20050136523 Catalytic enzyme-modified textiles for active protection from toxins
06/23/2005US20050136522 by passivation and adsorption; hydrolase enzyme immobilized within polyelectrolyte multilayers and a polymerizable end-capping layer; storage stable;
06/23/2005US20050136521 Separating a target protein (such as a recombinant protein produced in a cell culture) from a mixture by contacting mixture with a hydrophobic adsorbent comprising branched hydrocarbon functional groups in an aqueous salt solution and collecting the unbound flow-through fraction containing the target
06/23/2005US20050136519 Production of polyunsaturated fatty acids in oleaginous yeasts
06/23/2005US20050136515 Nucleotide sequences coding membrane protein for use in identifying modulators for prevention and treatment of cell proliferative, inflammatory, nervous system and autoimmune diseases
06/23/2005US20050136513 Selective incorporation of 5-hydroxytryptophan into proteins in mammalian cells
06/23/2005US20050136488 Identifying population of cells expressing fusion protein construct via fluorescent signal; diagnosing cancer